iPLATO

myGP

Competition 12 - General Practice of the Future

myGP provides a convenient, cost-effective communication platform to primary care. Its preGP signposting automation relieves the administrative burden on practices by directing patients to the most appropriate point of care.

Currently it is estimated that 27% of all face to face GP appointments could be managed by alternative means or at an alternate point of care. The acceleration of remote consultations in primary care because of COVID-19 has seen uptake of video consultations rise by almost 1,500% on the myGP platform.

The preGP element of the platform signposts patients based on their appointment reason to a more appropriate point of care, such as by telephone, nurse, or pharmacy. This innovation has reduced GP appointments by 26% - providing patients with education to avoid the ‘GP first’ mentality in England.

SBRI Healthcare provided myGP with funding, resources and guidance while completing its preGP with video consultation offering. An independent budget impact analysis showed that the technology could potentially deliver cumulative net saving to the NHS of £5.6million in the years to 2025 with demonstrable return of investment to the NHS and the national economy.

The need for remote consultation throughout the pandemic speaks for itself; practices relied on technology like the myGP app for patients to contact the surgery and order repeat medication. Practices relied on the platform to hold video consultations and send SMS communications to patients. myGP continues to gain traction and is present in over 6,500 GP practices in England

"With demand to see a GP rising by 25% over the last five years, we wanted to build a technology solution so that the right person had access to the right care at the right time, making things simpler for both GPs and practice staff, as well as patients. SBRI Healthcare supported us both financially and with resources, meaning that we had access to people to soundboard our decisions, this made our job easier and the result for the patient simpler"

Tobias Alpsten, CEO, iPLATO Healthcare**

• Adopted in 6,500 sites

• £3.5 million funding leveraged from private investment in 2020

• 63 members of staff across two countries

• Named in Sunday Times Tech Track

• Top 100 in 2019

• COVID-19: worked closely with NHS Digital to adapt myGP app and implement video consultations across primary care. Awarded places on the DPS and GPITF frameworks, naming myGP as an approved supplier of video consultation services.

• Personalised engagement reaching 15m+ people: Cancer screening, diabetes prevention, mental health and vaccination

• Digital First Online Consultation Video Consultation (DFOCVC) framework

• 45 CCGs have commissioned the iPLATO Platform

• NHS Digital Assured App with 2.5m patient users

• NHS Login Approved

• iPLATO merged with Huma Therapeutics who raised $250m